TissueLabs is building the platform for creating tissues and organs in the lab. 

TissueLabs was born with a singular, groundbreaking vision: to create the world’s first transplantable bioartificial heart. This mission stemmed from a deep, personal need to solve one of the most critical challenges in medicine—organ failure. As we pursued this bold goal, we quickly realized that the cutting-edge technologies we were developing for ourselves could have a far greater impact than we had initially imagined.

​

We saw that these innovations—designed to build life-saving therapies—could empower thousands of researchers around the world who were tackling their own challenges in regenerative medicine. Instead of keeping these advancements confined to our labs, we made a pivotal decision: to bring these technologies to the market and make them accessible to the global scientific community.

​

What began as a quest for a bioartificial heart transformed into a broader mission to democratize biofabrication. We turned every breakthrough—whether it was in advanced biomaterials or high-performance bioprinters—into products that researchers everywhere could use to unlock new possibilities in tissue engineering and organ creation.

​

Since then, our commitment has remained unwavering. Every technology we develop, we share with the world, ensuring that scientists everywhere have access to the best and most affordable tools. We believe that by making these innovations widely available, we can accelerate the pace of discovery and bring the future of medicine closer and faster.

​

Today, TissueLabs continues to lead with the same vision that started it all. We’re not only working toward creating a bioartificial heart—we’re empowering researchers around the globe with the tools they need to shape the future of healthcare.

Together, we’re building a world where biofabrication can transform lives.